CervoMed Closes $10 Million Stock Offering, Bolstering Cash Reserves
CRVO sits 89% above its 52-week low of $2.13.
Summary
CervoMed has closed its $10 million registered direct offering, selling 2.5 million common shares at $4.00 per share. This capital raise, which was announced on June 18th, follows a $10.5 million private placement that closed on June 10th. These combined financings are critical for the company, which had previously disclosed a going concern warning and a cash runway only into September 2026. The $10 million offering is highly dilutive but provides much-needed liquidity to extend operations.
At the time of this announcement, CRVO was trading at $4.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $38.2M. The 52-week trading range was $2.13 to $13.13. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.